GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia
Selina M Vattathil, Freida Blostein, Tyne W Miller-Fleming, Lea K Davis, Alzheimer's Disease Genetics Consortium (ADGC), Alzheimer's Disease Neuroimaging Initiative, Thomas S Wingo, Aliza P Wingo. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025-06
Topic: Genetics and APOE
Plain-language summary
We found genome-wide significant signals for agitation, anxiety, apathy, delusions, and hallucinations that were driven by the apolipoprotein E (APOE) ε4 allele. We replicated these findings in ADNI and BioVU cohorts. Mediation analyses revealed that, except for apathy, MCI/ADRD severity only partially mediated the GWAS signals. These findings suggest the APOE ε4 allele influences several NPS independently of and beyond its effect on ADRD. HIGHLIGHTS: Neuropsychiatric symptoms (NPS) are common in mild cognitive impairment and dementia. Effective NPS treatments are pressingly needed, and genetic studies can inform treatment targets to develop effective therapeutics. We conducted a genome-wide association study of NPS in over 12,800 individuals and a replication analysis in two independent cohorts. We found apolipoprotein E (APOE) single-nucleotide polymorphisms (SNPs) associated with multiple NPS domains beyond their effects on cognitive impairment.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Vattathil, S. M., Blostein, F., Miller-Fleming, T. W., Davis, L. K., Alzheimer's Disease Neuroimaging Initiative, Wingo, T. S., et al. (2025). GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.70329
Vancouver
Vattathil SM, Blostein F, Miller-Fleming TW, Davis LK, Alzheimer's Disease Neuroimaging Initiative, Wingo TS, et al. GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. doi:10.1002/alz.70329. PMID: 40495575.
BibTeX
@article{vattathil2025-40495575,
author = {Vattathil, Selina M and Blostein, Freida and Miller-Fleming, Tyne W and Davis, Lea K and {Alzheimer's Disease Neuroimaging Initiative} and Wingo, Thomas S and Wingo, Aliza P},
title = {{GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia}},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2025},
doi = {10.1002/alz.70329},
pmid = {40495575},
url = {https://doi.org/10.1002/alz.70329}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- We found genome-wide significant signals for agitation, anxiety, apathy, delusions, and hallucinations that were driven by the apolipoprotein E (APOE) ε4 allele.
- We replicated these findings in ADNI and BioVU cohorts.
- Mediation analyses revealed that, except for apathy, MCI/ADRD severity only partially mediated the GWAS signals.
- These findings suggest the APOE ε4 allele influences several NPS independently of and beyond its effect on ADRD.
- HIGHLIGHTS: Neuropsychiatric symptoms (NPS) are common in mild cognitive impairment and dementia.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Participants12,800
- Evidence strengthLow
How this study scored 59/100
Published in a leading specialty journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 33 of the 56 points we could judge it on, which is 59 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia : the journal of the Alzheimer's Association) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 12,800 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40495575) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 33 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 33 of the 56 points we could judge it on is 59 out of 100. |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “genetics”
346 studies in the library carry the topic tag “genetics”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 346 tagged studies.